Michelle Woods
Physician Assistant · Hickory, NCNPI 1982843637
Payments from drug & device makers
Across 263 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$635
- Bayer$440
- Novo Nordisk$399
- Xeris Pharmaceuticals, Inc.$359
- Medtronic$318
- AstraZeneca$308
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,746100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 43 | $635 |
| Bayer | 28 | $440 |
| Novo Nordisk | 27 | $399 |
| Xeris Pharmaceuticals, Inc. | 18 | $359 |
| Medtronic | 7 | $318 |
| AstraZeneca(2 entities) | 18 | $308 |
| Amgen | 13 | $244 |
| Corcept Therapeutics | 14 | $237 |
| Sanofi-aventis U.S. LLC | 12 | $220 |
| Abbott | 7 | $158 |
| Amneal Pharmaceuticals LLC | 9 | $151 |
| Dexcom, Inc. | 6 | $134 |
| AbbVie | 7 | $122 |
| Amarin Pharma, Inc. | 5 | $90 |
| Ascendis Pharma Endocrinology Inc | 4 | $87 |
| Recordati_rare_diseases_inc. | 4 | $86 |
| GRT US Holding, Inc. | 5 | $76 |
| Mannkind Corporation | 3 | $69 |
| Tandem Diabetes Care, Inc. | 4 | $69 |
| EUSA Pharma (US) LLC | 3 | $65 |
| Endo Pharmaceuticals Inc. | 4 | $64 |
| Pfizer | 3 | $59 |
| Insulet Corporation | 3 | $58 |
| Antares Pharma, Inc. | 2 | $49 |
| Boehringer Ingelheim | 3 | $43 |
| Cequr Corporation | 1 | $38 |
| Lifescan, Inc. | 2 | $37 |
| Clarus Therapeutics Inc. | 2 | $37 |
| Nevro Corp. | 2 | $33 |
| Novartis | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $14 |
How this compares
$4,762 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KorlymMifepristone | 14 | $432,368 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 142 | $123,967 |
| OzempicSemaglutide | 88 | $100,110 |
| Tresiba Flextouch U-200Insulin Degludec | 115 | $86,647 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 57 | $45,716 |
| JardianceEmpagliflozin | 71 | $42,723 |
| TrulicityDulaglutide | 35 | $38,625 |
| FarxigaDapagliflozin Propanediol | 48 | $33,019 |
| MounjaroTirzepatide | 18 | $28,165 |
| KerendiaFinerenone | 23 | $17,216 |
| Novolog FlexpenInsulin Aspart | 66 | $15,200 |
| Tresiba Flextouch U-100Insulin Degludec | 34 | $15,078 |
| Humalog Kwikpen U-100Insulin Lispro | 56 | $12,316 |
| Xigduo XrDapaglifloz Propaned/Metformin | 14 | $9,933 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $9,046 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Corcept TherapeuticsKorlym | $237 | $432,36814 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $220 | $123,967142 claims |
| Novo NordiskOzempic, Novolog | $399 | $104,424103 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $635 | $72,15571 claims |
| Boehringer IngelheimJardiance | $43 | $42,72371 claims |
| AstraZenecaFarxiga | $308 | $33,01948 claims |
| BayerKerendia | $440 | $17,21623 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $151 | $4,71788 claims |
| AbbVieSynthroid | $122 | $3,03137 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Hickory
- Sarah PadgettHickory$29K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.